Synthesis, characterization and biological applications of novel Schiff bases of 2-(trifluoromethoxy) aniline

doi:10.5246/jcps.2018.05.032

Abstract

Abstract:

A series of five new Schiff bases (1–5) were synthesized by reacting 2-(trifluoromethoxy) aniline with different aromatic aldehydes. The Schiff base compounds were characterized by spectroscopic and analytical methods. Crystal structure of one new compound was also reported. The pharmacological properties, including antibacterial (14 bacterial species), antifungal (7 strains),antimalarial, anti-trypanosomal and anti-HIV activities of the compounds, were investigated. Cytotoxicity of the tested compounds was evaluated against human cervix adernocarcinoma cells (HeLa). Bacterial minimum inhibitory concentration (MIC) results by broth microdilution method showed that Bacillus subtilis, Enterococcus faecalis, Staphylococcus aureus, Staphylococcus epidermidis, Proteus vulgaris, Klebsiella oxytoc and Klebsiella pneumonia were more sensitive in the presence of tested compounds with an MIC value of 15.6 µg/mL. All the tested compounds showed good to moderate activity against fungi. The sensitivity of Aspergillus fumigatus was higher than other strains with aminimum cell death concentration (MFC) of 15.6 µg/mL. Compound 1 showed greater antimalarial and anti-trypanosomal properties with very low to no cytotoxic effects against HeLa cells as compared with compound 5, while other compounds exhibited poor activity. Compounds 1–5 demonstrated good activity against HIV type-1. These Schiff base compounds could be used as good antimicrobial agents.

Key words: Synthesis, Biological activity, Schiff bases, Antimicrobial, 2-(Trifluoromethoxy) aniline

CLC Number:

R916

Supporting:

Thierry Youmbi Fonkui, Monisola Itohan Ikhile, Freddy Munyololo Muganza, Marthe Carine Djuidje Fotsing, Charmaine Arderne, Xavier Siwe-Noundou. Synthesis, characterization and biological applications of novel Schiff bases of 2-(trifluoromethoxy) aniline[J]. Journal of Chinese Pharmaceutical Sciences, 2018, 27(5): 307-323.

References

[1] Hussain, Z.; Yousif, E.; Ahmed, A.; Altaie, A. Synthesis and characterization of Schiff's bases of sulfamethoxazole. Org. Med. Chem. Lett. 2014, 4, 1-4.

[2] da Silva, C.M.; da Silva, D.L.; Modolo, L.V.; Alves, R.B.; de Resende, M.A.; Martins, C.V.B.; de Fátima, Â. Schiff bases: A short review of their antimicrobial activities. J. Adv. Res. 2011, 2, 1-8.

[3] Zhao, H.; Huang, B.; Wu, Y.; Cai, M. MCM-41-immobilized Schiff base-pyridine bidentate copper (I) complex as a highly efficient and recyclable catalyst for the Sonogashira reaction. J. Organometal. Chem. 2015, 797, 21-28.

[4] Alphonse, R.; Varghese, A.; George, L. Synthesis, characterization and photophysical studies of a novel schiff base bearing 1, 2, 4-Triazole scaffold. J. Mol. Struct. 2016, 1113, 60-69.

[5] Nag, S.; Mishra, A.; Batra, S. A facile route to the synthesis of pyrimido[2,1-b]quinazoline core from the primary allyl amines afforded from Baylis-Hillman adducts. Tetrahedron 2008, 64, 10162-10171.

[6] Neochoritis, C.G.; Zarganes-Tzitzikas, T.; Tsoleridis, C.A.; Stephanidou-Stephanatou, J.; Kontogiorgis, C.A.; Hadjipavlou-Litina, D.J.; Choli-Papadopoulou, T. One-pot microwave assisted synthesis under green chemistry conditions, antioxidant screening, and cytotoxicity assessments of benzimidazole Schiff bases and pyrimido[1,2-a]benzimidazol-3(4H)-ones. Eur. J. Med. Chem. 2011, 46, 297-306.

[7] Tomma, J.H.; Khazaal, M.S.; Al-Dujaili, A.H. Synthesis and characterization of novel Schiff bases containing pyrimidine unit. Arab. J. Chem. 2014, 7, 157-163.

[8] Mulunda, M.; Ndou, R.V.; Dzoma, B.; Nyirenda, M.; Bakunzi, F. Canine aflatoxicosis outbreak in South Africa (2011): a possible multi-mycotoxins aetiology. J. S. Afr. Vet. Assoc. 2013, E1, 84, 5.

[9] Olalekan, T.E.; Adejoro, I.A.; vanbrecht, B.; Watkins, G.M. Crystal structures, spectroscopic and theoretical study of novel Schiff bases of 2-(methylthiomethyl)anilines. Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 2015, 139, 385-395.

[10] Banerjee, S.; Horn, A.; Khatri, H.; Sereda, G. A green one-pot multicomponent synthesis of 4H-pyrans and polysubstituted aniline derivatives of biological, pharmacological, and optical applications using silica nanoparticles as reusable catalyst. Tetrahedron Lett. 2011, 52, 1878-1881.

[11] Calabrò, M.L.; Caputo, R.; Ettari, R.; Puia, G.; Ravazzini, F.; Zappalà, M.; Micale, N. Synthesis and biological evaluation of new 2-amino-6-(trifluoromethoxy)benzoxazole derivatives, analogues of riluzole. Med. Chem. Res. 2013, 22, 6089-6095.

[12] Lekha, L.; Kanmani Raja, K.; Rajagopal, G.; Easwaramoorthy, D. Schiff base complexes of rare earth metal ions: Synthesis, characterization and catalytic activity for the oxidation of aniline and substituted anilines. J. Organometal. Chem. 2014, 753, 72-80.

[13] Tao, N.; Liu, G.; Bai, L.; Tang, L.; Guo, C. Genotoxicity and growth inhibition effects of aniline on wheat. Chemosphere. 2017, 169, 467-473.

[14] Yıldız, M.; Karpuz, O.; Zeyrek, C.T.; Boyacıoglu, B.; Dal, H.; Demir, N.; Yıldırım, N.; Ünver, H. Synthesis, biological activity, DNA binding and anion sensors, molecular structure and quantum chemical studies of a novel bidentate Schiff base derived from 3,5-bis(triflouromethyl)aniline and salicylaldehyde. J. Mol. Struct. 2015, 1094, 148-160.

[15] Yılmaz, I.; Kazak, C.; Gümüş, S.; Ağar, E.; Ardalı, Y. (E)-3-Chloro-N-((5-nitrothiophen-2-yl)methylene)aniline: A combined crystallographic, theoretical and antimicrobial activity investigation. Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 2012, 97, 423-428.

[16] Alias, M.; Kassum, H.; Shakir, C. Synthesis, physical characterization and biological evaluation of Schiff base M (II) complexes. J. Assoc. Arab Univ. Basic Appl. Sci. 2014, 15, 28-34.

[17] Shoair, A.F.; El-Shobaky, A.R.; Abo-Yassin, H.R. Synthesis, spectroscopic characterization, catalytic and antibacterial studies of ruthenium (III) Schiff base complexes. J. Mol. Liq. 2015, 211, 217-227.

[18] Zhou, M.D.; Zang, S.L.; Herdtweck, E.; Kuhn, F.E. A (salicylidene)aniline derived Schiff-base adduct of methyltrioxorhenium (VII)-Cis-and trans-coordination of the ligand. J. Organometal. Chem. 2008, 693, 2473-2477.

[19] Thangavel, S.; Rajamanikandan, R.; Friedrich, H.B.; Ilanchelian, M.; Omondi, B. Binding interaction, conformational change, and molecular docking study of N-(pyridin-2-ylmethylene)aniline derivatives and carbazole Ru (II) complexes with human serum albumins. Polyhedron. 2016, 107, 124-135.

[20] Yousif, E.; Majeed, A.; Al-Sammarrae, K.; Salih, N.; Salimon, J.; Abdullah, B. Metal complexes of Schiff base: Preparation, characterization and antibacterial activity. Arab. J. Chem. 2017, 10, S1639-S1644.

[21] Bruker, Bruker AXS, Inc., Madison, WI, USA. 2015.

[22] Krause, L.; Herbst-Irmer, R.; Sheldrick, G.M.; Stalke, D. Comparison of silver and molybdenum microfocus X-ray sources for single-crystal structure determination. J. Appl. Crystallogr. 2015, 48, 3-10.

[23] Sheldrick, G.M. Crystal structure refinement with SHELXL. Acta Crystallogr. Sect. C Struct. Chem. 2015, 71, 3-8.

[24] Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H. OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339-341.

[25] Jogee, P.S.; Ingle, A.P.; Rai, M. Isolation and identification of toxigenic fungi from infected peanuts and efficacy of silver nanoparticles against them. Food Control. 2017, 71, 143-151.

[26] Venegas, B.; González-Damián, J.; Celis, H.; Ortega-Blake, I. Amphotericin B Channels in the Bacterial Membrane: Role of Sterol and Temperature. Biophys. J. 2003, 85, 2323-2332.

[27] CLSI, Clinical and Laboratory Standards Institute. 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA. 2008.

[28] Grobler, J.A.; Stillmock, K.; Hu, B.; Witmer, M.; Felock, P.; Espeseth, A.S.; Wolfe, A.; Egbertson, M.; Bourgeois, M.; Melamed, J.; Wai, J.S.; Young, S.; Vacca, J.; Hazuda, D.J. Diketo acid inhibitor mechanism and HIV-1 integrase: implications for metal binding in the active site of phosphotransferase enzymes. Proc. Natl. Acad. Sci. 2002, 99, 6661-6666.

[29] Lam, T.L.; Lam, M.L.; Au, T.K.; Ip, D.T.M.; Ng, T.B.; Fong, W.P.; Wan, D.C.C. A comparison of human immunodeficiency virus type-1 protease inhibition activities by the aqueous and methanol extracts of Chinese medicinal herbs. Life Sci. 2000, 67, 2889-2896.

[30] Naresh Kumar, K.; Ramesh, R. Synthesis, luminescent, redox and catalytic properties of Ru (II) carbonyl complexes containing 2N2O donors. Polyhedron. 2005, 24, 1885-1892.

[31] Rauf, A.; Shah, A.; Khan, A.A.; Shah, A.H.; Abbasi, R.; Qureshi, I.Z.; Ali, S. Synthesis, ph dependent photometric and electrochemical investigation, redox mechanism and biological applications of novel Schiff base and its metallic derivatives. Spectrochim. Acta. A. Mol. Biomol. Spectrosc. 2017, 176, 155-167.

[32] Bruno, I.J.; Cole, J.C.; Kessler, M.; Luo, J.; Motherwell, W.D.S.; Purkis, L.H.; Smith, B.R.; Taylor, R.; Cooper, R.I.; Harris, S.E.; Orpen, A.G. Retrieval of Crystallographically-Derived Molecular Geometry Information. J. Chem. Inf. Comput. Sci. 2004, 44, 2133-2144.

[33] Tang, Y.Z.; Liu, Z.Q. Quantitative structure-activity relationship of hydroxyl-substituent Schiff bases in radical-induced hemolysis of human erythrocytes. Cell Biochem. Funct. 2008, 26, 185-191.

[34] Royet, J.; Dziarski, R. Peptidoglycan recognition proteins: pleiotropic sensors and effectors of antimicrobial defenses. Nat. Rev. Microbiol. 2007, 5, 264-277.

[35] Qin, W.; Sha, L.; Panunzio, M.; Biondi, S. Schiff Bases: A Short Survey on an Evergreen Chemistry Tool. Molecules. 2013, 18, 12264-12289.

[36] Hazuda, D.J. Resistance to inhibitors of the human immunodeficiency virus type 1 integration. Bras. J. Infect. Dis. 2010, 14, 513.

[37] Mouscadet, J.F.; Tchertanov, L. Raltegravir: molecular basis of its mechanism of action. Eur. J. Med. Res. 2009, 14, 5-16.

[38] Ashraf, B.; Chi-Huey, W. HIV-1 protease: mechanism and drug discovery. Persective. 2003, 1, 5-14.
[39] Ambrose, Z.; Herman, B.D.; Sheen, C.; Zelina, S.; Moore, K.; Tachedjian, L.G.; Nissley, D.V.; Sluis-Cremer, N. The human immunodeficiency virus type 1 nonnucleoside reverse transcriptase inhibitor resistance mutation I132M confers hypersensitivity to nucleoside analogs. J. Virol. 2009, 83, 3826-3833.